(Q46660405)

English

Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers

scientific article published on 3 April 2008

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

Differential impact of conventional-dose and low-dose postmenopausal hormone therapy, tibolone and raloxifene on C-reactive protein and other inflammatory markers (English)

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

Per Morten Sandset

4

object named as

P M Sandset

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

2

object named as

L Sandvik

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

author name string

A L Eilertsen

1

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

B Steinsvik

3

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

publication date

3 April 2008

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

Journal of Thrombosis and Haemostasis

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

6

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

928-934

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

Hormone replacement therapy, heart disease, and other considerations

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

A prospective, observational study of postmenopausal hormone therapy and primary prevention of cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

The protective effects of estrogen on the cardiovascular system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

A clinical trial of estrogen-replacement therapy after ischemic stroke

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Raloxifene and cardiovascular events in osteoporotic postmenopausal women: four-year results from the MORE (Multiple Outcomes of Raloxifene Evaluation) randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Coagulation factors, inflammation markers, and venous thromboembolism: the longitudinal investigation of thromboembolism etiology (LITE).

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Inflammation, atherosclerosis, and coronary artery disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Inflammation in atherosclerosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Inflammation and thrombosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Von Willebrand factor, platelets and endothelial cell interactions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Conventional-dose hormone therapy (HT) and tibolone, but not low-dose HT and raloxifene, increase markers of activated coagulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Interrelationships among circulating interleukin-6, C-reactive protein, and traditional cardiovascular risk factors in women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Hormone replacement therapy and increased plasma concentration of C-reactive protein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Hormone replacement therapy: estrogen and progestin effects on plasma C-reactive protein concentrations.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

The effect of 17beta-estradiol on endothelial and inflammatory markers in postmenopausal women: a randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Significant differential effects of hormone therapy or tibolone on markers of cardiovascular disease in postmenopausal women: a randomized, double-blind, placebo-controlled, crossover study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Effects of tibolone and combined 17beta-estradiol and norethisterone acetate on serum C-reactive protein in healthy post-menopausal women: a randomized trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Short-term effects of hormone therapy on serum C-reactive protein levels in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

A cross-sectional study of the effects of hormon replacement therapy on the cardiovascular disease risk profile in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Effects of two continuous hormone therapy regimens on C-reactive protein and homocysteine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Effects of estrogen, raloxifene, and hormone replacement therapy on serum C-reactive protein and homocysteine levels

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Both raloxifene and estrogen reduce major cardiovascular risk factors in healthy postmenopausal women: A 2-year, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Vascular effects of synthetic or natural progestagen combined with conjugated equine estrogen in healthy postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Different effects of oral conjugated estrogen and transdermal estradiol on arterial stiffness and vascular inflammatory markers in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Increased levels of C-reactive protein after oral hormone replacement therapy may not be related to an increased inflammatory response

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Raloxifene, conjugated oestrogen and endothelial function in postmenopausal women

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Arterial disease and venous thrombosis: are they related, and if so, what should we do about it?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Progestins affect mechanism of estrogen-induced C-reactive protein stimulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1538-7836.2008.02970.X

21 January 2018

Identifiers

10.1111/J.1538-7836.2008.02970.X

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

release_czzkijx5ozh25mj6tdkfdxoqlm

1 reference

https://api.fatcat.wiki/v0/release/czzkijx5ozh25mj6tdkfdxoqlm

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

24 December 2017

http://europepmc.org/abstract/MED/18394014

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46660405&oldid=2125061819"